doi: 10.1097/gim.0b013e318159a38e.
Committee Report: advancing the current recommended panel of conditions for newborn screening
Affiliations
- PMID: 18007148
- DOI: 10.1097/gim.0b013e318159a38e
Item in Clipboard
Committee Report: advancing the current recommended panel of conditions for newborn screening
Genet Med.
2007 Nov.
Free article
Abstract
The Advisory Committee on Heritable Disorders and Genetic Diseases in Newborns and Children is charged with advising the Secretary of the US Department of Health and Human Services in areas relevant to heritable conditions in children, especially newborn screening (NBS). This report describes the formulation by the Committee of a new process to nominate and review conditions to the recommended universal NBS panel. Nominations are currently being solicited. Committee review will adhere to the fundamental principles of being transparent, broadly accessible, evidence-based and consistent across the process for all of the proposed conditions across the process.
Similar articles
-
From developing guidelines to implementing legislation: actions of the US Advisory Committee on Heritable Disorders in Newborns and Children toward advancing and improving newborn screening.Semin Perinatol. 2010 Apr;34(2):121-4. doi: 10.1053/j.semperi.2009.12.004. Semin Perinatol. 2010. PMID: 20207261
-
Including the initial newborn screening bloodspot collection device serial number on birth certificates: basis and recommendations from the Secretary of Health and Human Services' Advisory Committee on Heritable Disorders in Newborns and Children.Genet Med. 2013 Mar;15(3):229-33. doi: 10.1038/gim.2012.121. Epub 2012 Oct 4. Genet Med. 2013. PMID: 23037933
-
Decision-making process for conditions nominated to the recommended uniform screening panel: statement of the US Department of Health and Human Services Secretary's Advisory Committee on Heritable Disorders in Newborns and Children.Genet Med. 2014 Feb;16(2):183-7. doi: 10.1038/gim.2013.98. Epub 2013 Aug 1. Genet Med. 2014. PMID: 23907646
-
What questions should newborn screening long-term follow-up be able to answer? A statement of the US Secretary for Health and Human Services' Advisory Committee on Heritable Disorders in Newborns and Children.Genet Med. 2011 Oct;13(10):861-5. doi: 10.1097/GIM.0b013e3182209f09. Genet Med. 2011. PMID: 21716119
-
Newborn Screening: Beyond the Spot.Adv Exp Med Biol. 2017;1031:323-346. doi: 10.1007/978-3-319-67144-4_19. Adv Exp Med Biol. 2017. PMID: 29214581 Review.
Cited by
-
Population-Based Screening of Newborns: Findings From the NBS Expansion Study (Part One).Front Genet. 2022 Jul 22;13:867337. doi: 10.3389/fgene.2022.867337. eCollection 2022. Front Genet. 2022. PMID: 35938011 Free PMC article.
-
Association between use of systematic reviews and national policy recommendations on screening newborn babies for rare diseases: systematic review and meta-analysis.BMJ. 2018 May 9;361:k1612. doi: 10.1136/bmj.k1612. BMJ. 2018. PMID: 29743278 Free PMC article.
-
A Novel Targeted Screening Tool for Hypogammaglobulinemia: Measurement of Serum Immunoglobulin (IgG, IgM, IgA) Levels from Dried Blood Spots (Ig-DBS Assay).J Clin Immunol. 2015 Aug;35(6):573-82. doi: 10.1007/s10875-015-0184-y. Epub 2015 Aug 16. J Clin Immunol. 2015. PMID: 26275445 Free PMC article.
-
Genomics and perinatal care.N Engl J Med. 2012 Jan 5;366(1):64-73. doi: 10.1056/NEJMra1105043. N Engl J Med. 2012. PMID: 22216843 Free PMC article. Review. No abstract available.
-
Consensus statement: chromosomal microarray is a first-tier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies.Am J Hum Genet. 2010 May 14;86(5):749-64. doi: 10.1016/j.ajhg.2010.04.006. Am J Hum Genet. 2010. PMID: 20466091 Free PMC article. Review.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous
